Cathie Wood acquired 28.1 Million Recursion Pharmaceuticals shares worth $182 Million. That's 1.64% of their equity portfolio (22nd largest holding). The investor owns 9.79% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares nine more times and sold shares on three occasions. The investor's estimated purchase price is $288 Million, resulting in a loss of 37%.
Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today’s market. Indeed, shares of RXRX stock are rocketing more t...
InvestorPlace, 8 months agoCathie Wood just gave the company a huge vote of confidence.
The Motley Fool, 10 months ago